Follow the ALEXION PHARMACEUTICALS INC stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 8 February 2016 (Attribution). Among the most active insiders: Sinha Vikas. The full history is free.
101
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
90 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
435 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000240:7
25 of 101 declarations
About ALEXION PHARMACEUTICALS INC
ALEXION PHARMACEUTICALS INC is a biopharmaceutical company focused on developing treatments for rare and severe diseases. It specializes in the research and commercialization of innovative drugs to improve patients' lives.